Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents

/unibl/sci/idNaucniRad:28718

Пронађите сличне уносеConference Paper

Пронађите сличне уносеtext

Пронађите сличне уносе2021-09

I. Risović, M. Bojic, D. Djekic, Benefits of insulin glargine/lixisenatide fixed-ratio combination for patients inadequately controlled on premixed insulin and oral agents, Diabetologia 64, 1–380 (2021), Sep, 2021

57 th EASD

Пронађите сличне уносеDiabetologia 64, 1–380 (2021)